Middle meningeal artery embolization for chronic subdural hematoma in elderly patients at high risk of surgical treatment
Journal of Cerebrovascular and Endovascular Neurosurgery
; : 28-35, 2023.
Article
em En
| WPRIM
| ID: wpr-967093
Biblioteca responsável:
WPRO
ABSTRACT
Objective@#The purpose of this study was to evaluate the effectiveness of middle meningeal artery embolization (MMAE) in elderly high-risk patients with symptomatic chronic subdural hematoma (CSDH) in terms of reduction in hematoma volume and recurrence rate. @*Methods@#We retrospectively reviewed data prospectively collected from nine patients who underwent 13 MMAE for CSDH between June 2017 and May 2022. The volume of the subdural hematoma was measured using a computer-aided volumetric analysis program. Hematoma volume changes during the follow-up period were analyzed and clinical outcomes were evaluated. @*Results@#The mean follow-up period was 160 days (range, 46−311 days). All procedures were technically successful and there were no procedure-related complications. Of the 13 MMAE, 84% (11 out of 13 hemispheres) showed mean 88% of reduction on follow-up volumetric study with eight cases of complete resolution. There was one refractory case with MMAE which had been performed multiple burr-hole trephinations, for which treatment was completed by craniotomy and meticulous resection of multiple pseudomembranes. There was no recurrent case during the follow-up period, except for refractory case. @*Conclusions@#MMAE for CSDH in selected high-risk elderly patients and relapsed patients might be effective. Despite the small cohort, our findings showed a high rate of complete resolution with no complications. Further prospective randomized trials are warranted to evaluate its usefulness as a primary treatment option for CSDH.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
En
Revista:
Journal of Cerebrovascular and Endovascular Neurosurgery
Ano de publicação:
2023
Tipo de documento:
Article